Results 231 to 240 of about 1,171,691 (282)

Current Understanding of Protein Aggregation in Neurodegenerative Diseases. [PDF]

Int J Mol Sci
Hu C, Lin M, Wang C, Zhang S.
europepmc   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source

Thermodynamics and Transport Properties of Heavy Aromatics in a Mixture of DMSO and Toluene Solvents. [PDF]

ACS Omega
Taherkhani F.
europepmc   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

Molecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak, Karolina Pytlak, Sandra Jaworowska, Bogusz Kulawiak, Piotr Bednarczyk   +4 more
wiley   +1 more source

The low complexity linker of DNAJB6b is key to its anti-amyloid function. [PDF]

QRB Discov
Merkelis T, Olsson U, Linse S.
europepmc   +1 more source

Human RBM3 protein is prone to form neuronal aggregates opposed by the proteasome. [PDF]

Biol Open
Kumar S, Kleven T, Ciosk R.
europepmc   +1 more source

From synaptic guardian to neurodegenerative culprit: rewiring the amyloid-β feedback loop in Alzheimer's disease. [PDF]

J Clin Invest
Herz J.
europepmc   +1 more source